Answers are grounded in this paper and cite their sources.
Many studies have been conducted to evaluate the effectiveness and safety of immune checkpoint inhibitors in metastatic breast cancer, but the results were not conclusive. The present network meta-analysis aimed to assess the effectiveness and safety of PD-1/PD-L1 inhibitors in different types of metastatic breast cancer. PubMed, Scopus, Web of Science, The Cochrane Library and ClinicalTrials.gov were searched. The primary outcomes were progression-free survival (PFS) and overall survival (OS). Safety was considered as secondary outcomes. Cochrane Risk-Of-Bias (RoB2) was used for the quality assessment of relevant articles. Random effect model was used for meta-analysis in the clinically relevant subgroups ( e.g., PD-L1/PD-1±, previously untreated/ refractory, and triple negative/hormone positive). In this network meta-analysis, 9 studies ( n =3785) were included. Our results revealed that in triple negative breast cancer patients, only durvalumab was associated with statistically significant improved OS (HR=0.49, 95%CrI=[0.30,0.80]) and atezolizumab + chemotherapy improved significantly PFS (HR=0.70,95%CrI=[0.38,0.92]). In PD-L1 positive subgroup, only atezolizumab + chemotherapy significantly improved PFS (HR=0.68,95%CrI=[0.42,0.99]) and OS (HR=0.63,95%CrI=[0.35,0.92]) compared with chemotherapy. In previously untreated subjects, only atezolizumab + chemotherapy significantly improved PFS (HR= 0.70, 95% CrI= [0.37, 0.91]) compared with chemotherapy. No significant difference was observed in adverse events of the comparisons while pembrolizumab + chemotherapy had more probability to cause adverse events when compared with chemotherapy. PD-1/PD-L1 inhibitors can more significantly improve PFS in the PD-L1 positive, previously untreated and metastatic triple negative breast cancer patients. However, more high-qualified trials must be still conducted to provide more definitive result for clinical practice.
No takes yet. Share an insight, caveat, or question.
Beyki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: